Ovid Therapeutics Inc (NASDAQ:OVID)

1.85
Delayed Data
As of 3:06pm ET
 +0.01 / +0.54%
Today’s Change
1.65
Today|||52-Week Range
3.78
-42.37%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$130.3M

Company Description

Ovid Therapeutics, Inc. is a biopharmaceutical company, engaged in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

Contact Information

Ovid Therapeutics, Inc.
1460 Broadway
New York New York 10036
P:(646) 661-7661
Investor Relations:
(917) 943-6681

Employees

Shareholders

Other institutional40.19%
Individual stakeholders30.92%
Mutual fund holders11.91%

Top Executives

Jeremy Max LevinChairman, President & Chief Executive Officer
Jason TardioChief Operating Officer
Jeffrey A. RonaChief Financial & Business Officer
Claude NicaiseHead-Research & Development
Julia TsaiSenior VP-Clinical Development & Medical Affairs